A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease

References

• Stolz D, Mkorombindo T, Schumann DM, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921–972. doi:10.1016/S0140-6736(22)01273-9
   PubMed Web of Science ®Google Scholar
• Hurst JR, Han MK, Singh B, et al. Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review. Respir Res. 2022;23(1):213. doi:10.1186/s12931-022-02123-5
   PubMed Web of Science ®Google Scholar
• Lareau SC, Fahy B, Meek P, et al. Chronic Obstructive Pulmonary Disease (COPD). Am J Respir Crit Care Med. 2019;199(1):P1–P2. doi:10.1164/rccm.1991P1
   PubMed Web of Science ®Google Scholar
• Jeyachandran V, Hurst JR. Advances in chronic obstructive pulmonary disease: management of exacerbations. Br J Hosp Med. 2022;83(7):1–7. doi:10.12968/hmed.2022.0275
   Web of Science ®Google Scholar
• Zhou J, Zhang J, Zhou M, et al. The role of long-acting muscarinic antagonist/long-acting beta agonist fixed-dose combination treatment for chronic obstructive pulmonary disease in China: a narrative review. J Thorac Dis. 2021;13(11):6453–6467. doi:10.21037/jtd-21-961
   PubMed Web of Science ®Google Scholar
• Criner GJ, Celli BR, Brightling CE, et al. Benralizumab for the prevention of COPD exacerbations. N Engl J Med. 2019;381(11):1023–1034. doi:10.1056/NEJMoa1905248
   PubMed Web of Science ®Google Scholar
• Stoeppel CM, Eriksson EA, Diaz-Flores R, et al. Guiding the management of intubated patients with pneumonia and ventilator-associated events using serial catheter-directed bronchoalveolar lavage. J Trauma Acute Care Surg. 2014;76(5):1264–1269. doi:10.1097/TA.0000000000000219
   PubMed Web of Science ®Google Scholar
• Feng Z, Zhang L, Yu H, et al. High-flow nasal cannula oxygen therapy versus non-invasive ventilation for AECOPD patients after extubation: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2022;17:1987–1999. doi:10.2147/COPD.S375107
   PubMed Web of Science ®Google Scholar
• Kohnlein T, Schwarz SB, Nagel S, et al. Home Non-invasive positive pressure ventilation in chronic obstructive pulmonary disease: why, who, and how?. Respiration. 2022;101(8):709–716. doi:10.1159/000525015
   PubMed Web of Science ®Google Scholar
• Hu H, Ji Z, Qiang X, et al. Chinese medical injections for acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis. Int J Chron Obstruct Pulmon Dis. 2021;16:3363–3386. doi:10.2147/COPD.S335579
   PubMed Web of Science ®Google Scholar
• Liang C, Mao X, Niu H, et al. characteristics, management and in-Hospital clinical outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in China: results from the Phase I data of ACURE study. Int J Chron Obstruct Pulmon Dis. 2021;16:451–465. doi:10.2147/COPD.S281957
   PubMed Web of Science ®Google Scholar
• Baqdunes MW, Leap J, Young M, et al. Acute exacerbation of chronic obstructive pulmonary disease. Crit Care Nurs Q. 2021;44(1):74–90. doi:10.1097/CNQ.0000000000000341
   PubMed Web of Science ®Google Scholar
• Jones SE, Barker RE, Nolan CM, et al. Pulmonary rehabilitation in patients with an acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2018;10(Suppl 12):S1390–S1399. doi:10.21037/jtd.2018.03.18
   PubMed Web of Science ®Google Scholar
• Roverso M, Dogra R, Visentin S, et al. Mass spectrometry-based “omics” technologies for the study of gestational diabetes and the discovery of new biomarkers. Mass Spectrom Rev. 2022. doi:10.1002/mas.21777
   PubMed Web of Science ®Google Scholar
• Doni F, Suhaimi NSM, Mispan MS, et al. Microbial contributions for rice production: from conventional crop management to the use of “Omics” technologies. Int J Mol Sci. 2022;23(2). doi:10.3390/ijms23020737
   PubMed Web of Science ®Google Scholar
• Bansal N, Kumar M, Sankhwar SN, et al. Relevance of emerging metabolomics-based biomarkers of prostate cancer: a systematic review. Expert Rev Mol Med. 2022;24:e25. doi:10.1017/erm.2022.20
   PubMed Web of Science ®Google Scholar
• Di Minno A, Gelzo M, Caterino M, et al. Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine. Int J Mol Sci. 2022;23(9):5213. doi:10.3390/ijms23095213
   PubMed Web of Science ®Google Scholar
• Benchoula K, Vohra MS, Parhar IS, et al. Metabolomics based biomarker identification of anti-diabetes and anti-obesity properties of Malaysian herbs. Metabolomics. 2022;18(2):12. doi:10.1007/s11306-022-01870-2
   PubMed Web of Science ®Google Scholar
• Aderemi AV, Ayeleso AO, Oyedapo OO, et al. Metabolomics: a scoping review of its role as a tool for disease biomarker discovery in selected non-communicable diseases. Metabolites. 2021;11(7):418. doi:10.3390/metabo11070418
   PubMed Web of Science ®Google Scholar
• Arshad H, Siokis A, Franke R, et al. Reprogramming of amino acid metabolism differs between community-acquired pneumonia and infection-associated exacerbation of chronic obstructive pulmonary disease. Cells. 2022;11(15):2283. doi:10.3390/cells11152283
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang H, Si Y, et al. High-coverage lipidomics analysis reveals biomarkers for diagnosis of acute exacerbation of chronic obstructive pulmonary disease. J Chromatogr B Analyt Technol Biomed Life Sci. 2022;1201–1202:123278. doi:10.1016/j.jchromb.2022.123278
   PubMed Web of Science ®Google Scholar
• Gai X, Guo C, Zhang L, et al. Serum glycerophospholipid profile in acute exacerbation of chronic obstructive pulmonary disease. Front Physiol. 2021;12:646010. doi:10.3389/fphys.2021.646010
   PubMed Web of Science ®Google Scholar
• Zhou J, Li Q, Liu C, et al. Plasma metabolomics and lipidomics reveal perturbed metabolites in different disease stages of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2020;15:553–565. doi:10.2147/COPD.S229505
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang AH, Miao JH, et al. Metabolomics biotechnology, applications, and future trends: a systematic review. RSC Adv. 2019;9(64):37245–37257. doi:10.1039/C9RA06697G
   PubMed Web of Science ®Google Scholar
• Shao M, Lu Y, Xiang H, et al. Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine. Front Pharmacol. 2022;13:971561. doi:10.3389/fphar.2022.971561
   PubMed Web of Science ®Google Scholar
• Nambiar S, Bong How S, Gummer J, et al. Metabolomics in chronic lung diseases. Respirology. 2020;25(2):139–148. doi:10.1111/resp.13530
   PubMed Web of Science ®Google Scholar
• Ghosh N, Dutta M, Singh B, et al. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Expert Rev Mol Diagn. 2016;16(8):897–913. doi:10.1080/14737159.2016.1198258
   PubMed Web of Science ®Google Scholar
• Donaldson K, Buchanich JM, Grigson PS, et al.Abstracts of presentations at the association of clinical scientists 143(rd) meeting Louisville, KY May 11–14, 2022. Ann Clin Lab Sci. 2022;52(3):511–525.
   PubMedGoogle Scholar
• Ruiz-Gonzalez A, Saez-Huerta E, Martinez-Alonso M, et al. A simple scoring system to differentiate bacterial from viral infections in acute exacerbations of COPD requiring hospitalization. Int J Chron Obstruct Pulmon Dis. 2022;17:773–779. doi:10.2147/COPD.S356950
   PubMed Web of Science ®Google Scholar
• MacNee W. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. Ann Med. 2013;45(3):291–300. doi:10.3109/07853890.2012.732703
   PubMed Web of Science ®Google Scholar
• Wei B, Tian T, Liu Y, et al. The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease. BMC Pulm Med. 2020;20(1):237. doi:10.1186/s12890-020-01265-w
   PubMed Web of Science ®Google Scholar
• Adamko DJ, Nair P, Mayers I, et al. Metabolomic profiling of asthma and chronic obstructive pulmonary disease: a pilot study differentiating diseases. J Allergy Clin Immunol. 2015;136(3):571–580 e573. doi:10.1016/j.jaci.2015.05.022
   PubMed Web of Science ®Google Scholar
• Xue M, Zeng Y, Lin R, et al. Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease. Exp Biol Med. 2021;246(14):1586–1596. doi:10.1177/15353702211008808
   PubMed Web of Science ®Google Scholar
• Mathioudakis AG, Janssens W, Sivapalan P, et al. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits. Thorax. 2020;75(6):520–527. doi:10.1136/thoraxjnl-2019-214484
   PubMed Web of Science ®Google Scholar